StonvexLoading…
StonvexStonvexStonvexCore line items from SHBI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $5.39M | $20.85M | $15.48M | $10.35M |
Operating Income | $22.66M | $78.66M | $57.87M | $38.89M |
Net Income | $17.09M | $59.51M | $43.62M | $15.51M |
EPS (Diluted) | $0.51 | $1.78 | $1.31 | $0.88 |
Total Assets | $6.21B | $6.26B | $6.28B | $6.04B |
Total Liabilities | $5.60B | $5.67B | $5.70B | $5.47B |
Cash & Equivalents | $340.82M | $355.57M | $416.51M | $184.98M |
Free Cash Flow OCF − CapEx | $30.49M | $59.22M | $51.42M | $9.54M |
Shares Outstanding | 33.45M | 33.41M | 33.42M | 33.37M |